V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320003757 | 320002281 | 1.71 | 64 | Adjuvant (A) | 2016-02-09 | 2016-02-28 | Carboplatin + Etoposide iv&po | N | Y | 320024013 | CETUXIMAB + RT |
| 320003758 | 320002282 | 1.68 | 93.9 | Palliative (P) | null | 2015-05-26 | BLEOMYCIN | null | null | 320024014 | CARBOPLATIN + PEMETREXED |
| 320003759 | 320002282 | 1.6 | null | null | null | 2013-04-07 | DOCETAXEL + Prednisolone | null | null | 320024014 | CAPECITABINE + CISPLATIN |
| 320003760 | 320002283 | 1.5 | 57.5 | Palliative (P) | 2013-09-17 | 2013-10-04 | Bevacizumab+Carbo+Pacliaxel | N | N | 320024026 | MPV |
| 320003761 | 320002284 | 1.68 | 62.2 | Palliative (P) | 2013-11-01 | 2013-11-04 | BEVACIZUMAB + CARBO | N | N | 320024027 | OXALIPLATIN + MDG |
| 320003762 | 320002285 | 1.72 | 62 | Palliative (P) | null | 2014-05-13 | CARBOPLATIN + VINORELBINE | 02 | N | 320024029 | CARBOPLATIN + VINORELBINE |
| 320003766 | 320002287 | 1.82 | 94 | Curative (C) | null | 2016-09-15 | Cisplatin + Docetaxel +Fluorouracil | Y | y | 320024039 | NOT MATCHED |
| 320003767 | 320002288 | 1.74 | 59 | Neo-adjuvant (N) | 2013-09-22 | 2013-09-28 | Cisplatin + Docetaxel +Fluorouracil | N | N | 320024042 | CARBO + FLUOROURACIL |
| 320003768 | 320002289 | null | 64.8 | Curative (C) | 2017-09-17 | 2017-09-20 | Cisplatin + Etoposide (3 day) | N | N | 320024052 | BCG |
| 320003769 | 320002290 | 1.75 | 69.2 | Curative (C) | 2016-01-07 | 2016-01-12 | BCG Intravesical | 02 | N | 320024053 | CAPECITABINE + MITOMYCIN |
| 320003770 | 320002291 | 1.75 | 61.35 | Neo-adjuvant (N) | 2014-03-27 | 2014-03-28 | CompARE Trial | N | N | 320024055 | BCG |
| 320003771 | 320002292 | 1.94 | 77.1 | Curative (C) | 2017-06-18 | 2017-06-19 | Fluorouracil+Mitomycin+RT (Bladder) | N | N | 320024056 | CISPLATIN + GEMCITABINE |
| 320003772 | 320002293 | 1.63 | null | Neo-adjuvant (N) | 2017-06-11 | 2017-06-13 | Cetuximab +Cisplatin + FU (Cycle 1) | N | null | 320024058 | PEMBROLIZUMAB |
| 320003773 | 320002293 | 1.58 | 55.8 | Palliative (P) | 2018-09-02 | 2018-09-27 | Docetaxel + Trastuzumab (Maint) | N | N | 320024058 | STREPTOZOCIN + MDG |
| 320003774 | 320002293 | 1.6 | 64.7 | Palliative (P) | null | 2016-07-06 | Hydroxycarbamide | N | N | 320024058 | ICON TRIAL |
| 320003775 | 320002293 | null | 92.25 | Curative (C) | 2016-11-08 | 2016-12-20 | ICON8 TRIAL | N | Y | 320024058 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 320003776 | 320002294 | 1.48 | 0 | Adjuvant (A) | 2015-11-07 | 2015-11-23 | Docetaxel 75mg/m2 (21 day) | 2 | N | 320024082 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003777 | 320002295 | 0 | 123.4 | Palliative (P) | 2014-04-23 | 2014-05-27 | CARBO + FLUOROURACIL | N | N | 320024083 | CAPECITABINE + CARBOPLATIN |
| 320003778 | 320002296 | 1.64 | 70 | Curative (C) | 2015-05-15 | 2015-06-01 | Capecitabine | N | N | 320024085 | CARBOPLATIN + LIPOSOMAL DOX |
| 320003779 | 320002297 | 1.65 | 8.1 | Palliative (P) | 2016-09-13 | 2016-09-21 | CAP | 2 | N | 320024088 | ENZALUTAMIDE |
| 320003780 | 320002298 | null | 74.4 | Palliative (P) | 2016-12-30 | 2017-01-24 | CETUXIMAB + RT | N | N | 320024091 | MITOMYCIN INTRAVESICULAR |
| 320003781 | 320002299 | 1.51 | 64 | Curative (C) | 2015-07-22 | 2015-07-29 | Paclitaxel (2 or 3 weekly) | null | N | 320024115 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320003782 | 320002300 | null | 56.4 | null | 2016-07-08 | 2016-07-11 | ICON8 TRIAL | N | null | 320025218 | NOT MATCHED |
| 320003783 | 320002301 | 1.64 | 57.8 | Adjuvant (A) | 2015-01-26 | 2015-01-27 | FEC 100 | Y | null | 320000073 | TRIAL |
| 320003784 | 320002302 | null | null | 3 | null | 2016-10-11 | Bevacizumab + CARBOPLATIN + PACLITAXEL | null | null | 320000366 | DOXORUBICIN + IFOSFAMIDE |
| 320003785 | 320002303 | 1.48 | 76.5 | Palliative (P) | 2017-02-18 | 2017-02-22 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 320000420 | ICON8B TRIAL |
| 320003786 | 320002303 | 0 | 80.8 | Neo-adjuvant (N) | null | 2016-10-15 | CARBOPLATIN + ETOPOSIDE | 01 | N | 320000420 | BEVACIZUMAB |
| 320003787 | 320006377 | 1.64 | 50.8 | Curative (C) | 2016-09-11 | 2016-09-16 | CETUXIMAB | N | N | 320000735 | CARBOPLATIN + ETOPOSIDE |
| 320003788 | 320002304 | 1.75 | 75.45 | Neo-adjuvant (N) | null | 2018-09-18 | CAPECITABINE + CETUXIMAB + CISPLATIN | N | N | 320000915 | EOX |
| 320003789 | 320002305 | 1.63 | 62.2 | Curative (C) | 2015-07-30 | 2015-08-06 | Bevacizumab 7.5mg/kg | N | N | 320001140 | ICON8B TRIAL |
| 320003790 | 320002306 | 1.6 | 78 | Neo-adjuvant (N) | 2017-10-22 | 2017-10-22 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 320001321 | CARBOPLATIN + ETOPOSIDE |
| 320003791 | 320002306 | null | 21.3 | Neo-adjuvant (N) | 2017-01-02 | 2017-01-08 | Trial Unspecified | 2 | N | 320001321 | CETUXIMAB + RT |
| 320003792 | 320002307 | null | 69.7 | Adjuvant (A) | 2016-08-14 | 2016-10-03 | Cisplatin + Docetaxel +Fluorouracil | N | Y | 320001641 | VINFLUNINE |
| 320003793 | 320002308 | 1.58 | 66 | Curative (C) | 2014-10-06 | 2014-10-06 | Carboplatin + Pemetrexed | 02 | N | 320002399 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320003794 | 320002309 | 1.64 | null | Palliative (P) | null | 2015-07-26 | Bevacizumab 7.5mg/kg | null | null | 320002508 | CARBOPLATIN + RT |
| 320003795 | 320002310 | 1.77 | null | Palliative (P) | null | 2017-06-16 | Carboplatin + Vinorelbine Oral | null | null | 320002593 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003796 | 320002310 | 1.69 | 0 | Neo-adjuvant (N) | null | 2018-05-12 | EC | N | N | 320002593 | OXALIPLATIN + MDG |
| 320003797 | 320002311 | null | 73 | Curative (C) | 2018-01-10 | 2018-01-25 | Cisplatin + Etoposide (3 day) | null | null | 320002638 | VINBLASTINE |
| 320003798 | 320002312 | 1.55 | 84.4 | Curative (C) | 2017-05-22 | 2017-06-24 | CETUXIMAB + RT | 02 | N | 320002724 | TRIAL |
| 320003799 | 320002313 | null | 99.5 | null | 2017-09-27 | 2017-10-11 | IVADo | N | N | 320002938 | IVADO |
| 320003800 | 320002313 | 1.8 | 74 | Palliative (P) | 2017-11-20 | 2017-12-02 | EOX | 2 | N | 320002938 | CARBO + FLUOROURACIL |
| 320003801 | 320002314 | 1.68 | 54 | null | 2017-01-20 | 2017-02-06 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | Y | 320003094 | ICON8B TRIAL |
| 320003802 | 320002315 | 1.77 | 53.2 | Palliative (P) | 2016-03-15 | 2016-03-15 | Carboplatin + Etoposide IV 3 day | 2 | N | 320003119 | IPILIMUMAB |
| 320003803 | 320002316 | null | 65 | Palliative (P) | 2017-06-11 | 2017-06-11 | Temozolomide + RT | N | null | 320003387 | IMATINIB |
| 320003804 | 320002317 | 1.91 | 88.9 | Palliative (P) | 2014-10-09 | 2014-10-09 | Trial Unspecified | 02 | null | 320003389 | CISPLATIN + FLUOROURACIL + RT |
| 320003805 | 320002318 | 1.74 | null | Palliative (P) | 2018-11-08 | 2018-11-13 | Capecitabine + Cisplatin | 02 | N | 320003483 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003806 | 320005082 | null | null | Palliative (P) | 2015-09-22 | 2015-09-30 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | N | 320003526 | CARBOPLATIN + DOCETAXEL |
| 320003807 | 320002319 | null | 48.4 | Palliative (P) | 2016-10-12 | 2016-10-23 | FLUOROURACIL + OXALIPLATIN | N | N | 320003697 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320003808 | 320005083 | 1.64 | null | Palliative (P) | 2018-02-26 | 2018-03-14 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 320003739 | ICON TRIAL |
| 320003809 | 320005083 | 1.74 | 88 | Palliative (P) | 2016-04-08 | 2016-04-30 | CISPLATIN + FLUOROURACIL + RT | null | N | 320003739 | CETUXIMAB + RT |